PREGABALIN

PREGABALIN was reported 274153 times

PREGABALIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 C-REACTIVE PROTEIN 482 0.5200
1 DEEP VEIN THROMBOSIS POSTOPERATIVE 915 0.4568
2 LUPUS VULGARIS 496 0.3937
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 251 0.3757
4 SWOLLEN JOINT COUNT INCREASED 1105 0.3462
5 NEUROLOGIC NEGLECT SYNDROME 178 0.3201
6 RHEUMATIC FEVER 1188 0.2662
7 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 541 0.2608
8 FACET JOINT SYNDROME 832 0.2553
9 X-RAY ABNORMAL 426 0.2380
10 RETINITIS 411 0.2377
11 SUBSTANCE USE DISORDER 752 0.2358
12 CAROTID ARTERY THROMBOSIS 192 0.2261
13 AMAUROSIS FUGAX 242 0.2247
14 DISLOCATION OF VERTEBRA 512 0.2243
15 RHEUMATOID FACTOR POSITIVE 1245 0.2153
16 SERONEGATIVE ARTHRITIS 210 0.1832
17 DUODENAL ULCER PERFORATION 1337 0.1796
18 C-REACTIVE PROTEIN ABNORMAL 1097 0.1708
19 PRE-EXISTING CONDITION IMPROVED 1029 0.1647
20 FIBROMYALGIA 4006 0.1646
21 ADJUSTMENT DISORDER 208 0.1600
22 DRUG USE DISORDER 1345 0.1598
23 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 995 0.1531
24 PORPHYRIA ACUTE 214 0.1491
25 HELICOBACTER INFECTION 1432 0.1392
26 SCIATICA 2155 0.1350
27 PERSONALITY DISORDER 341 0.1301
28 MUSCLE INJURY 1077 0.1299
29 BONE EROSION 434 0.1226
30 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 869 0.1212
31 POST HERPETIC NEURALGIA 174 0.1210
32 FEELING DRUNK 886 0.1191
33 FOLLICULITIS 1247 0.1188
34 DRUG TOLERANCE DECREASED 328 0.1167
35 PERIPHERAL VENOUS DISEASE 470 0.1150
36 DIABETIC NEUROPATHY 558 0.1126
37 BRADYPNOEA 299 0.1107
38 WITHDRAWAL SYNDROME 4512 0.1073
39 AUTOIMMUNE DISORDER 1046 0.1072
40 RADICULOPATHY 282 0.1069
41 SYSTEMIC INFECTION 176 0.1061
42 NEURALGIA 2577 0.1059
43 HAND DEFORMITY 1370 0.1043
44 SYNOVITIS 1861 0.1031
45 FEMALE GENITAL TRACT FISTULA 175 0.1024
46 JOINT RANGE OF MOTION DECREASED 1348 0.1004
47 BURSITIS 1218 0.1003
48 PRESCRIBED OVERDOSE 1923 0.0993
49 MIOSIS 794 0.0988
50 LIP DRY 898 0.0988
51 TEMPERATURE REGULATION DISORDER 218 0.0978
52 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1028 0.0928
53 RHEUMATOID NODULE 254 0.0921
54 EUPHORIC MOOD 941 0.0918
55 GRIP STRENGTH DECREASED 791 0.0898
56 BLOOD PRESSURE DIASTOLIC ABNORMAL 228 0.0896
57 CHRONIC SINUSITIS 327 0.0870
58 HYPERCHOLESTEROLAEMIA 838 0.0867
59 WOUND INFECTION 926 0.0845
60 BLOOD PRESSURE SYSTOLIC ABNORMAL 207 0.0837
61 PEMPHIGUS 1046 0.0836
62 MACULAR DEGENERATION 978 0.0818
63 INTERNATIONAL NORMALISED RATIO FLUCTUATION 167 0.0806
64 BREAST CANCER STAGE III 519 0.0801
65 TRIGEMINAL NEURALGIA 322 0.0800
66 DRUG TOLERANCE 399 0.0788
67 IMPAIRED DRIVING ABILITY 867 0.0762
68 EXOSTOSIS 694 0.0759
69 BREATH SOUNDS ABNORMAL 370 0.0750
70 NERVE INJURY 829 0.0745
71 IRRITABLE BOWEL SYNDROME 1597 0.0744
72 WALKING AID USER 490 0.0742
73 PLEURITIC PAIN 205 0.0742
74 LOWER LIMB FRACTURE 1416 0.0736
75 DYSAESTHESIA 225 0.0733
76 HYPERPARATHYROIDISM SECONDARY 180 0.0718
77 ALTERED STATE OF CONSCIOUSNESS 1550 0.0715
78 BRONCHIECTASIS 481 0.0713
79 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 439 0.0710
80 NEPHROGENIC ANAEMIA 318 0.0686
81 SPINAL DISORDER 649 0.0685
82 URINARY TRACT DISORDER 308 0.0683
83 BODY HEIGHT DECREASED 724 0.0676
84 INTERVERTEBRAL DISC DISORDER 288 0.0674
85 MYOCLONUS 803 0.0673
86 SENSORY LOSS 540 0.0670
87 GLOSSODYNIA 1492 0.0666
88 SUBSTANCE ABUSE 539 0.0662
89 PERICARDITIS 1112 0.0661
90 APPARENT DEATH 238 0.0660
91 WOUND 1846 0.0660
92 PROCTITIS 177 0.0631
93 SPONDYLITIS 227 0.0624
94 ALCOHOL POISONING 166 0.0619
95 CLUMSINESS 168 0.0615
96 INTERVERTEBRAL DISC DEGENERATION 566 0.0611
97 ACTIVITIES OF DAILY LIVING IMPAIRED 1210 0.0610
98 INTERVERTEBRAL DISC PROTRUSION 1333 0.0609
99 THINKING ABNORMAL 1133 0.0607
100 JOINT DISLOCATION 642 0.0607
101 SPINAL STENOSIS 250 0.0605
102 RESPIRATORY DEPRESSION 741 0.0604
103 BACK DISORDER 982 0.0603
104 COORDINATION ABNORMAL 835 0.0598
105 SOMNOLENCE 11964 0.0594
106 HYPOPNOEA 205 0.0590
107 DYSPHEMIA 258 0.0588
108 FOOT DEFORMITY 650 0.0586
109 LUMBAR SPINAL STENOSIS 171 0.0585
110 CONTRAINDICATED PRODUCT ADMINISTERED 1768 0.0583
111 PULMONARY FIBROSIS 1115 0.0581
112 POTENTIATING DRUG INTERACTION 195 0.0581
113 CREPITATIONS 173 0.0580
114 ROAD TRAFFIC ACCIDENT 2399 0.0573
115 COMA 2729 0.0573
116 DRUG EFFECT INCOMPLETE 2076 0.0571
117 HYPERAESTHESIA 460 0.0559
118 DYSGRAPHIA 368 0.0558
119 SYSTEMIC LUPUS ERYTHEMATOSUS 1974 0.0556
120 ANXIETY DISORDER 185 0.0553
121 DRUG ABUSE 4593 0.0551
122 SPINAL OSTEOARTHRITIS 484 0.0550
123 SENSITIVITY TO WEATHER CHANGE 289 0.0549
124 SPINAL COLUMN STENOSIS 259 0.0548
125 TYPE 2 DIABETES MELLITUS 1842 0.0547
126 GANGRENE 329 0.0545
127 PSORIATIC ARTHROPATHY 2216 0.0545
128 OBESITY 868 0.0544
129 OSTEOARTHRITIS 2280 0.0537
130 BRADYPHRENIA 351 0.0537
131 LYME DISEASE 179 0.0536
132 INTENTIONAL PRODUCT MISUSE 4694 0.0536
133 GAIT INABILITY 1782 0.0533
134 LIVE BIRTH 446 0.0533
135 ANTINUCLEAR ANTIBODY POSITIVE 173 0.0532
136 SPINAL FUSION SURGERY 216 0.0532
137 MATERNAL EXPOSURE TIMING UNSPECIFIED 199 0.0529
138 ARTHROPATHY 2940 0.0528
139 DIPLOPIA 1362 0.0524
140 IMPAIRED HEALING 1721 0.0524
141 WEIGHT INCREASED 11716 0.0523
142 LIVER INJURY 1282 0.0522
143 IMPAIRED WORK ABILITY 1100 0.0514
144 LUPUS-LIKE SYNDROME 466 0.0513
145 DELIRIUM 1779 0.0512
146 MUSCLE SPASTICITY 618 0.0502
147 SPINAL PAIN 584 0.0498
148 BEDRIDDEN 654 0.0497
149 SNORING 187 0.0494
150 SOPOR 654 0.0493
151 OEDEMA 2667 0.0491
152 FEELING OF BODY TEMPERATURE CHANGE 288 0.0491
153 FEELING OF DESPAIR 228 0.0488
154 MOTOR DYSFUNCTION 498 0.0488
155 DYSARTHRIA 1838 0.0488
156 FORMICATION 338 0.0485
157 BENIGN PROSTATIC HYPERPLASIA 249 0.0482
158 LOGORRHOEA 169 0.0479
159 INTENTIONAL PRODUCT USE ISSUE 4170 0.0476
160 NERVE COMPRESSION 439 0.0475
161 PNEUMONIA ASPIRATION 1177 0.0471
162 DRY MOUTH 3816 0.0470
163 HAEMORRHAGIC STROKE 366 0.0468
164 AMNESIA 3035 0.0466
165 DEPRESSED LEVEL OF CONSCIOUSNESS 1836 0.0464
166 DRUG INTOLERANCE 4465 0.0462
167 SEDATION 1207 0.0460
168 DISTURBANCE IN ATTENTION 2473 0.0458
169 PRESCRIBED UNDERDOSE 911 0.0456
170 IRON DEFICIENCY 205 0.0455
171 SLEEP DISORDER 3216 0.0455
172 BURNING SENSATION 3177 0.0453
173 BRADYKINESIA 267 0.0452
174 LIMB DISCOMFORT 1389 0.0448
175 OEDEMA PERIPHERAL 5463 0.0448
176 CONFUSIONAL STATE 7183 0.0444
177 RESTLESS LEGS SYNDROME 806 0.0443
178 MUSCULOSKELETAL PAIN 2298 0.0438
179 DYSSTASIA 1278 0.0437
180 HYPOAESTHESIA 6545 0.0437
181 SYNOVIAL CYST 201 0.0435
182 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2087 0.0434
183 NEUROPATHY PERIPHERAL 4132 0.0434
184 HIP ARTHROPLASTY 665 0.0434
185 ATAXIA 514 0.0433
186 MONOPLEGIA 188 0.0432
187 JOINT EFFUSION 298 0.0432
188 PAIN 26532 0.0431
189 MOBILITY DECREASED 3101 0.0431
190 MUSCLE TWITCHING 989 0.0429
191 GENERALISED OEDEMA 530 0.0428
192 ARTERIAL OCCLUSIVE DISEASE 336 0.0427
193 AFFECTIVE DISORDER 336 0.0427
194 HYPOKINESIA 620 0.0427
195 GAIT DISTURBANCE 8169 0.0426
196 CARPAL TUNNEL SYNDROME 597 0.0426
197 WHEEZING 2526 0.0426
198 C-REACTIVE PROTEIN INCREASED 1549 0.0425
199 BLOOD CHOLESTEROL INCREASED 1978 0.0424
200 BALANCE DISORDER 3656 0.0423
201 RHEUMATOID ARTHRITIS 4798 0.0422
202 POST-TRAUMATIC STRESS DISORDER 283 0.0422
203 MEMORY IMPAIRMENT 5797 0.0422
204 JOINT SWELLING 5085 0.0421
205 MYDRIASIS 540 0.0420
206 HEAD DISCOMFORT 745 0.0420
207 MENTAL IMPAIRMENT 1019 0.0420
208 AFFECT LABILITY 404 0.0419
209 SPUTUM DISCOLOURED 398 0.0419
210 OBSTRUCTIVE AIRWAYS DISORDER 461 0.0414
211 SLEEP APNOEA SYNDROME 790 0.0414
212 SPEECH DISORDER 2164 0.0413
213 FACIAL PAIN 368 0.0412
214 POISONING 517 0.0411
215 INFUSION RELATED REACTION 2727 0.0411
216 LOCAL SWELLING 716 0.0410
217 VITAMIN D DEFICIENCY 400 0.0410
218 ASPIRATION 448 0.0409
219 MUSCULOSKELETAL STIFFNESS 3567 0.0407
220 FOOD ALLERGY 313 0.0405
221 BLOOD PRESSURE DIASTOLIC INCREASED 187 0.0405
222 VISION BLURRED 5546 0.0404
223 NIGHT SWEATS 1301 0.0403
224 HEMIPLEGIA 334 0.0401
225 SWELLING 3757 0.0401
226 TENDERNESS 417 0.0400
227 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2807 0.0394
228 SUICIDAL BEHAVIOUR 164 0.0394
229 BEHAVIOUR DISORDER 213 0.0393
230 PAIN IN EXTREMITY 11501 0.0390
231 ANKLE FRACTURE 597 0.0385
232 SUICIDAL IDEATION 3526 0.0385
233 DISORIENTATION 1526 0.0385
234 POOR QUALITY SLEEP 827 0.0384
235 FRUSTRATION TOLERANCE DECREASED 309 0.0382
236 WEIGHT FLUCTUATION 400 0.0382
237 JOINT STIFFNESS 1002 0.0382
238 PANIC REACTION 275 0.0381
239 BLISTER 2129 0.0379
240 GLUCOSE TOLERANCE IMPAIRED 224 0.0378
241 THERAPEUTIC RESPONSE UNEXPECTED 1699 0.0378
242 ABASIA 935 0.0378
243 LIGAMENT SPRAIN 374 0.0378
244 MOVEMENT DISORDER 1207 0.0376
245 ARTHRITIS 2945 0.0374
246 FEELING ABNORMAL 8942 0.0373
247 MENISCUS INJURY 229 0.0372
248 HALLUCINATION, VISUAL 786 0.0372
249 INCREASED APPETITE 710 0.0371
250 PERONEAL NERVE PALSY 211 0.0371
251 HERPES ZOSTER 2125 0.0369
252 LOWER RESPIRATORY TRACT INFECTION 1680 0.0369
253 INSOMNIA 9838 0.0369
254 PERIPHERAL SWELLING 5682 0.0368
255 MIDDLE INSOMNIA 686 0.0367
256 PHOTOPHOBIA 689 0.0366
257 DYSKINESIA 1484 0.0365
258 CONCUSSION 282 0.0364
259 MAJOR DEPRESSION 266 0.0364
260 RESTLESSNESS 1330 0.0363
261 SOMNAMBULISM 238 0.0362
262 FOOT FRACTURE 687 0.0362
263 LYMPHOEDEMA 249 0.0360
264 COGNITIVE DISORDER 1681 0.0360
265 KNEE ARTHROPLASTY 757 0.0359
266 FOETAL DEATH 186 0.0358
267 INFLAMMATION 1850 0.0358
268 SCOLIOSIS 222 0.0358
269 GENERAL PHYSICAL HEALTH DETERIORATION 4115 0.0355
270 HEPATIC ENZYME INCREASED 2423 0.0355
271 HYPERSOMNIA 1014 0.0353
272 IMMUNODEFICIENCY 526 0.0352
273 ULCER 561 0.0352
274 POLYNEUROPATHY 422 0.0352
275 JOINT INJURY 752 0.0352
276 ULCER HAEMORRHAGE 238 0.0351
277 BACK INJURY 382 0.0351
278 HYPOACUSIS 1510 0.0350
279 PARALYSIS 502 0.0350
280 GINGIVAL PAIN 279 0.0350
281 BLEPHAROSPASM 220 0.0349
282 BLOOD PRESSURE SYSTOLIC INCREASED 680 0.0348
283 LIVER DISORDER 1544 0.0348
284 RALES 202 0.0347
285 INCOHERENT 225 0.0347
286 DISCOMFORT 2120 0.0347
287 TOXIC ENCEPHALOPATHY 176 0.0347
288 NECK PAIN 1937 0.0346
289 APHASIA 1046 0.0346
290 LUNG DISORDER 1692 0.0345
291 INADEQUATE ANALGESIA 293 0.0345
292 OCULAR DISCOMFORT 387 0.0344
293 MULTIPLE ALLERGIES 270 0.0344
294 SKIN ULCER 888 0.0343
295 EATING DISORDER 731 0.0343
296 SKIN ABRASION 162 0.0342
297 HEPATIC CIRRHOSIS 643 0.0342
298 ROTATOR CUFF SYNDROME 438 0.0341
299 PAROSMIA 257 0.0340
300 ATELECTASIS 327 0.0338
301 POISONING DELIBERATE 320 0.0337
302 RIB FRACTURE 692 0.0336
303 FALL 11142 0.0334
304 LIMB INJURY 909 0.0334
305 SENSORY DISTURBANCE 537 0.0334
306 URINARY RETENTION 1114 0.0334
307 PERIPHERAL COLDNESS 457 0.0332
308 TOXICITY TO VARIOUS AGENTS 5576 0.0330
309 MUSCULAR WEAKNESS 3753 0.0330
310 MICTURITION URGENCY 376 0.0329
311 SINUSITIS 3367 0.0328
312 TENSION 200 0.0328
313 URINARY INCONTINENCE 972 0.0328
314 PARAESTHESIA ORAL 470 0.0325
315 BRAIN INJURY 326 0.0325
316 BODY TEMPERATURE DECREASED 320 0.0325
317 OSTEOPOROSIS 1337 0.0325
318 DRUG INTERACTION 5155 0.0325
319 INCONTINENCE 343 0.0324
320 TREMOR 5379 0.0324
321 RHINITIS 259 0.0321
322 THERAPEUTIC PRODUCT EFFECT DECREASED 1437 0.0321
323 COELIAC DISEASE 312 0.0318
324 STOMATITIS 1926 0.0317
325 EAR PAIN 612 0.0314
326 PARAESTHESIA 4921 0.0312
327 PERSONALITY CHANGE 290 0.0312
328 BLOOD PRESSURE FLUCTUATION 746 0.0310
329 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1705 0.0310
330 INTENTIONAL SELF-INJURY 627 0.0310
331 VITAMIN D DECREASED 265 0.0310
332 END STAGE RENAL DISEASE 563 0.0308
333 INTENTIONAL OVERDOSE 1980 0.0308
334 HEARING IMPAIRED 185 0.0308
335 PARKINSONISM 300 0.0307
336 DECREASED INTEREST 181 0.0307
337 FAECALOMA 168 0.0306
338 UPPER RESPIRATORY TRACT INFECTION 1416 0.0306
339 TREATMENT FAILURE 2532 0.0305
340 NIGHTMARE 1054 0.0304
341 ON AND OFF PHENOMENON 169 0.0304
342 ACCIDENT 362 0.0303
343 DIZZINESS 15042 0.0301
344 MUSCULOSKELETAL DISCOMFORT 519 0.0301
345 SEROTONIN SYNDROME 579 0.0301
346 DEPRESSION 6840 0.0300
347 SINUS CONGESTION 406 0.0300
348 DYSURIA 1105 0.0300
349 DRUG WITHDRAWAL SYNDROME 2634 0.0300
350 CONTUSION 2887 0.0300
351 BLOOD PRESSURE DIASTOLIC DECREASED 221 0.0299
352 HAND FRACTURE 212 0.0299
353 ORAL CANDIDIASIS 394 0.0299
354 CRYING 1087 0.0299
355 PANIC ATTACK 1090 0.0299
356 LOCALISED INFECTION 723 0.0299
357 BLADDER DISORDER 296 0.0298
358 ARTERIOSCLEROSIS CORONARY ARTERY 197 0.0297
359 MALAISE 13009 0.0296
360 EAR INFECTION 789 0.0296
361 MIGRAINE 2828 0.0296
362 FULL BLOOD COUNT ABNORMAL 313 0.0296
363 LIVER FUNCTION TEST INCREASED 635 0.0295
364 IMPAIRED QUALITY OF LIFE 424 0.0295
365 CYSTITIS 937 0.0294
366 AGITATION 2147 0.0292
367 IMPAIRED GASTRIC EMPTYING 398 0.0292
368 VERTIGO 1778 0.0291
369 HYPERLIPIDAEMIA 348 0.0291
370 AGGRESSION 1455 0.0290
371 SCREAMING 185 0.0290
372 PRODUCT PRESCRIBING ERROR 691 0.0290
373 CONDITION AGGRAVATED 8816 0.0290
374 TINNITUS 1328 0.0289
375 HYPERHIDROSIS 3695 0.0287
376 UPPER LIMB FRACTURE 571 0.0286
377 SWOLLEN TONGUE 894 0.0286
378 HEPATIC STEATOSIS 533 0.0286
379 NERVOUSNESS 1492 0.0285
380 CARDIAC MURMUR 247 0.0285
381 PYELONEPHRITIS 247 0.0285
382 CEREBRAL DISORDER 210 0.0284
383 PRESYNCOPE 689 0.0283
384 ANKYLOSING SPONDYLITIS 373 0.0283
385 SINUS DISORDER 560 0.0282
386 COLD SWEAT 498 0.0282
387 SPINAL COMPRESSION FRACTURE 233 0.0282
388 HALLUCINATION 2123 0.0281
389 SPINAL OPERATION 347 0.0281
390 FREQUENT BOWEL MOVEMENTS 759 0.0281
391 RENAL CYST 223 0.0281
392 MOUTH SWELLING 162 0.0280
393 HALLUCINATION, AUDITORY 446 0.0280
394 APATHY 409 0.0280
395 BACK PAIN 6503 0.0280
396 SUICIDE ATTEMPT 1693 0.0279
397 LOSS OF CONSCIOUSNESS 3577 0.0279
398 MUSCLE DISORDER 226 0.0279
399 THERMAL BURN 198 0.0279
400 DECUBITUS ULCER 227 0.0278
401 VISUAL FIELD DEFECT 201 0.0278
402 SINUS BRADYCARDIA 267 0.0276
403 MUSCULOSKELETAL DISORDER 525 0.0276
404 VISUAL IMPAIRMENT 3400 0.0274
405 INJURY 1924 0.0273
406 EPILEPSY 836 0.0273
407 FEELING COLD 761 0.0273
408 HYPERTENSION 5790 0.0273
409 HEMIPARESIS 463 0.0273
410 HYPOTHERMIA 276 0.0272
411 PHOTOSENSITIVITY REACTION 450 0.0272
412 HEAD INJURY 862 0.0272
413 ANAL INCONTINENCE 245 0.0272
414 CATARACT 1622 0.0272
415 DEPRESSED MOOD 1439 0.0272
416 DIABETES MELLITUS 2074 0.0272
417 WRIST FRACTURE 326 0.0272
418 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1418 0.0271
419 BLOOD TEST ABNORMAL 381 0.0271
420 ASTHMA 3062 0.0271
421 GAMMA-GLUTAMYLTRANSFERASE INCREASED 600 0.0270
422 ANGER 915 0.0270
423 EYE DISORDER 885 0.0269
424 FLANK PAIN 251 0.0268
425 FLUID RETENTION 1361 0.0267
426 HEPATOCELLULAR INJURY 379 0.0267
427 LYMPHOCYTE COUNT DECREASED 472 0.0267
428 ADRENAL INSUFFICIENCY 324 0.0267
429 ANXIETY 7576 0.0266
430 PULMONARY THROMBOSIS 290 0.0266
431 CHRONIC KIDNEY DISEASE 2014 0.0265
432 ASPHYXIA 216 0.0264
433 INFECTION 3826 0.0264
434 MUSCLE TIGHTNESS 428 0.0264
435 UNRESPONSIVE TO STIMULI 680 0.0263
436 MUSCLE RIGIDITY 315 0.0263
437 APHONIA 367 0.0263
438 BLINDNESS 1071 0.0263
439 RHABDOMYOLYSIS 1096 0.0263
440 PELVIC FRACTURE 204 0.0262
441 NERVOUS SYSTEM DISORDER 817 0.0261
442 BRONCHITIS 1934 0.0261
443 MUSCLE SPASMS 4786 0.0261
444 GASTROOESOPHAGEAL REFLUX DISEASE 2096 0.0260
445 DRUG ERUPTION 461 0.0260
446 PURPURA 230 0.0260
447 IRRITABILITY 1560 0.0259
448 PHARYNGEAL OEDEMA 399 0.0259
449 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 229 0.0259
450 TEMPERATURE INTOLERANCE 266 0.0258
451 OSTEOPENIA 391 0.0257
452 DECREASED IMMUNE RESPONSIVENESS 252 0.0257
453 VISUAL ACUITY REDUCED 853 0.0257
454 GLAUCOMA 494 0.0256
455 TUBULOINTERSTITIAL NEPHRITIS 480 0.0256
456 PRODUCT ADMINISTRATION INTERRUPTED 201 0.0256
457 TONGUE DISORDER 185 0.0255
458 ELECTROCARDIOGRAM ABNORMAL 200 0.0255
459 TACHYCARDIA 2264 0.0255
460 BONE DISORDER 463 0.0254
461 SKIN HAEMORRHAGE 376 0.0253
462 HAEMATEMESIS 643 0.0253
463 PARANOIA 437 0.0253
464 SLUGGISHNESS 258 0.0253
465 NEUTROPHIL COUNT INCREASED 259 0.0253
466 INTERSTITIAL LUNG DISEASE 1220 0.0252
467 DISABILITY 498 0.0252
468 DRUG SCREEN POSITIVE 199 0.0252
469 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 430 0.0251
470 ACUTE KIDNEY INJURY 3835 0.0250
471 DISSOCIATION 192 0.0250
472 APPETITE DISORDER 166 0.0250
473 INTENTIONAL DRUG MISUSE 522 0.0249
474 OXYGEN SATURATION DECREASED 1399 0.0249
475 GASTROINTESTINAL DISORDER 2227 0.0248
476 ABNORMAL BEHAVIOUR 984 0.0248
477 NASOPHARYNGITIS 4576 0.0248
478 NAIL DISORDER 217 0.0248
479 BLOOD IRON DECREASED 294 0.0248
480 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 420 0.0247
481 DELUSION 384 0.0247
482 BIPOLAR DISORDER 268 0.0246
483 MUSCULOSKELETAL CHEST PAIN 381 0.0246
484 IRON DEFICIENCY ANAEMIA 227 0.0246
485 CONSTIPATION 5344 0.0245
486 MUSCLE STRAIN 211 0.0244
487 SPINAL FRACTURE 488 0.0243
488 MYOSITIS 218 0.0243
489 BRAIN OEDEMA 306 0.0242
490 HYPERCALCAEMIA 299 0.0242
491 MOOD ALTERED 660 0.0242
492 HUNGER 337 0.0242
493 ANGINA PECTORIS 693 0.0242
494 UROSEPSIS 223 0.0241
495 CHOLESTASIS 464 0.0241
496 HYPERKALAEMIA 847 0.0241
497 HYPOTONIA 241 0.0241
498 MENTAL DISORDER 1050 0.0241
499 RECTAL HAEMORRHAGE 1035 0.0241
500 EYE PAIN 1350 0.0239
501 ACCIDENTAL OVERDOSE 873 0.0238
502 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 245 0.0238
503 HERNIA 461 0.0238
504 CELLULITIS 1197 0.0237
505 HYPERTHERMIA 181 0.0237
506 MULTIPLE SCLEROSIS 1129 0.0236
507 HYPONATRAEMIA 1327 0.0235
508 POOR VENOUS ACCESS 242 0.0234
509 PSYCHOTIC DISORDER 690 0.0233
510 ILL-DEFINED DISORDER 1414 0.0233
511 FEAR 625 0.0232
512 ARTHRALGIA 9654 0.0232
513 SWELLING FACE 1511 0.0232
514 FACIAL PARALYSIS 197 0.0231
515 RESPIRATORY DISORDER 691 0.0231
516 THYROID DISORDER 356 0.0231
517 PNEUMONIA 7462 0.0230
518 PSYCHIATRIC SYMPTOM 170 0.0230
519 WEIGHT DECREASED 6429 0.0230
520 VAGINAL DISCHARGE 233 0.0230
521 ENCEPHALOPATHY 565 0.0230
522 HYPERSENSITIVITY 4260 0.0229
523 CARDIO-RESPIRATORY ARREST 957 0.0229
524 NOCTURIA 277 0.0228
525 GENERALISED TONIC-CLONIC SEIZURE 377 0.0228
526 GROIN PAIN 200 0.0228
527 DYSPHAGIA 2157 0.0227
528 DYSPEPSIA 2229 0.0226
529 THERAPY NON-RESPONDER 1017 0.0226
530 EOSINOPHILIA 396 0.0226
531 TOOTH FRACTURE 249 0.0226
532 PRODUCT USE ISSUE 4244 0.0226
533 FACE OEDEMA 380 0.0225
534 QUALITY OF LIFE DECREASED 302 0.0225
535 HYPOKALAEMIA 1037 0.0224
536 FAECES SOFT 163 0.0224
537 CYST 278 0.0224
538 PULMONARY MASS 333 0.0223
539 RESPIRATORY TRACT CONGESTION 353 0.0222
540 CONVULSION 1269 0.0222
541 EMOTIONAL DISORDER 684 0.0222
542 PSYCHOMOTOR HYPERACTIVITY 368 0.0222
543 HYPOTHYROIDISM 708 0.0221
544 TOOTH DISORDER 492 0.0221
545 BLOOD PRESSURE INCREASED 3377 0.0221
546 MEDICATION ERROR 1227 0.0221
547 ASTHENIA 8296 0.0220
548 SEIZURE 2535 0.0219
549 SKIN LESION 602 0.0219
550 MUSCLE ATROPHY 278 0.0219
551 HIATUS HERNIA 283 0.0218
552 SNEEZING 487 0.0217
553 RENAL PAIN 230 0.0217
554 BRADYCARDIA 1149 0.0216
555 FEELING HOT 1325 0.0216
556 INITIAL INSOMNIA 221 0.0215
557 HAEMATOMA 558 0.0215
558 DECREASED APPETITE 5002 0.0215
559 SYNCOPE 2147 0.0214
560 DEAFNESS 561 0.0214
561 DYSPNOEA EXERTIONAL 808 0.0214
562 DRUG LEVEL INCREASED 355 0.0214
563 RENAL TUBULAR NECROSIS 210 0.0214
564 URINE OUTPUT DECREASED 187 0.0214
565 GASTRIC ULCER 406 0.0213
566 PRODUCTIVE COUGH 1018 0.0213
567 SEASONAL ALLERGY 300 0.0212
568 AKATHISIA 289 0.0212
569 URINARY TRACT INFECTION 3611 0.0211
570 HYPOGLYCAEMIA 1026 0.0211
571 BASAL CELL CARCINOMA 330 0.0211
572 NODULE 276 0.0211
573 HEADACHE 13249 0.0211
574 ABDOMINAL DISCOMFORT 3536 0.0211
575 SKIN LACERATION 229 0.0210
576 ABNORMAL DREAMS 581 0.0210
577 AGRANULOCYTOSIS 391 0.0210
578 DRUG-INDUCED LIVER INJURY 660 0.0210
579 HYPOAESTHESIA ORAL 317 0.0210
580 FRACTURE 398 0.0210
581 BLOOD CREATINE PHOSPHOKINASE INCREASED 605 0.0210
582 SEXUAL DYSFUNCTION 246 0.0210
583 FEELING JITTERY 399 0.0209
584 GASTROINTESTINAL PAIN 230 0.0209
585 SCRATCH 220 0.0208
586 BREAST CANCER STAGE II 173 0.0208
587 DENTAL CARIES 230 0.0208
588 PYREXIA 7193 0.0208
589 APHTHOUS ULCER 161 0.0207
590 TENDONITIS 321 0.0207
591 DIVERTICULITIS 574 0.0207
592 PULMONARY CONGESTION 273 0.0207
593 GASTROENTERITIS 302 0.0207
594 DRUG DEPENDENCE 3327 0.0207
595 CHEST PAIN 3831 0.0207
596 DEMENTIA 578 0.0207
597 HEART RATE DECREASED 726 0.0207
598 ORTHOSTATIC HYPOTENSION 360 0.0207
599 DRUG INEFFECTIVE 27242 0.0206
600 INFLUENZA 2305 0.0206
601 TOOTHACHE 372 0.0205
602 OSTEOMYELITIS 372 0.0205
603 WHITE BLOOD CELL COUNT INCREASED 786 0.0205
604 KIDNEY INFECTION 402 0.0205
605 BLOOD POTASSIUM DECREASED 615 0.0204
606 CIRCULATORY COLLAPSE 347 0.0204
607 FATIGUE 15861 0.0204
608 ORAL HERPES 397 0.0203
609 ABDOMINAL PAIN UPPER 4182 0.0203
610 MYALGIA 3453 0.0203
611 TRANSAMINASES INCREASED 451 0.0203
612 SKIN INFECTION 227 0.0202
613 SCAR 346 0.0202
614 BLOOD UREA INCREASED 338 0.0202
615 GASTRITIS 531 0.0202
616 LETHARGY 1160 0.0201
617 COMPLETED SUICIDE 1675 0.0201
618 PROCEDURAL PAIN 557 0.0201
619 MOOD SWINGS 639 0.0200
620 TRANSIENT ISCHAEMIC ATTACK 676 0.0200
621 NEPHROPATHY 187 0.0200
622 HAEMATOCHEZIA 1105 0.0200
623 DIZZINESS POSTURAL 194 0.0200
624 SCHIZOPHRENIA 243 0.0200
625 BLOOD CALCIUM INCREASED 175 0.0199
626 TOOTH ABSCESS 203 0.0199
627 PALLOR 542 0.0199
628 MENTAL STATUS CHANGES 552 0.0199
629 ILEUS 247 0.0199
630 LIP SWELLING 661 0.0198
631 VOMITING 9312 0.0198
632 DIABETES MELLITUS INADEQUATE CONTROL 350 0.0197
633 HYPOXIA 695 0.0197
634 SALIVARY HYPERSECRETION 197 0.0197
635 ERYTHEMA MULTIFORME 183 0.0196
636 SKIN DISORDER 654 0.0196
637 RENAL FAILURE 2602 0.0196
638 TOXIC EPIDERMAL NECROLYSIS 297 0.0195
639 GASTROENTERITIS VIRAL 353 0.0195
640 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 161 0.0195
641 DRY EYE 972 0.0195
642 ABDOMINAL PAIN 4526 0.0194
643 BLOOD ALKALINE PHOSPHATASE INCREASED 482 0.0194
644 STAPHYLOCOCCAL INFECTION 640 0.0194
645 FEEDING DISORDER 393 0.0194
646 RESPIRATORY TRACT INFECTION 503 0.0193
647 CHILLS 2262 0.0193
648 HEPATITIS 492 0.0192
649 SEPSIS 2142 0.0192
650 EAR DISCOMFORT 196 0.0191
651 RENAL DISORDER 887 0.0190
652 BLOOD TRIGLYCERIDES INCREASED 336 0.0190
653 PALPITATIONS 2223 0.0190
654 BODY TEMPERATURE INCREASED 387 0.0189
655 HEART RATE IRREGULAR 428 0.0189
656 IMMUNE SYSTEM DISORDER 249 0.0189
657 OVERDOSE 4075 0.0189
658 BLOOD MAGNESIUM DECREASED 163 0.0189
659 DYSPHONIA 1103 0.0188
660 URTICARIA 3147 0.0188
661 DYSPNOEA 10626 0.0188
662 BLOOD POTASSIUM INCREASED 304 0.0187
663 HAEMATURIA 641 0.0187
664 NAUSEA 14728 0.0186
665 PULMONARY OEDEMA 833 0.0186
666 PREGNANCY 372 0.0186
667 DEHYDRATION 2465 0.0185
668 GLOMERULAR FILTRATION RATE DECREASED 227 0.0185
669 TOXIC SKIN ERUPTION 186 0.0184
670 MOUTH ULCERATION 389 0.0184
671 GASTRIC DISORDER 633 0.0184
672 PHARYNGITIS 228 0.0184
673 CARDIOMEGALY 226 0.0184
674 HEPATIC CYTOLYSIS 234 0.0183
675 DERMATITIS CONTACT 209 0.0183
676 BLOOD PRESSURE ABNORMAL 364 0.0183
677 GRAND MAL CONVULSION 169 0.0183
678 CANDIDA INFECTION 309 0.0183
679 MANIA 301 0.0183
680 ERECTILE DYSFUNCTION 469 0.0182
681 HYPOPHAGIA 466 0.0182
682 BONE PAIN 1066 0.0182
683 BLOOD SODIUM DECREASED 342 0.0181
684 HIP FRACTURE 583 0.0181
685 HYPOTENSION 3624 0.0180
686 PRODUCT DISPENSING ERROR 393 0.0180
687 DECREASED ACTIVITY 194 0.0180
688 SECRETION DISCHARGE 225 0.0179
689 ACUTE RESPIRATORY FAILURE 345 0.0179
690 RHINORRHOEA 1151 0.0178
691 HAEMORRHOIDS 347 0.0178
692 PNEUMONIA BACTERIAL 163 0.0177
693 MULTIPLE SCLEROSIS RELAPSE 1215 0.0177
694 THROMBOCYTOPENIA 1978 0.0177
695 TOOTH INFECTION 233 0.0177
696 ASCITES 519 0.0176
697 GOUT 316 0.0176
698 ABDOMINAL DISTENSION 1837 0.0176
699 RASH 7644 0.0175
700 BLOOD PRESSURE DECREASED 1164 0.0175
701 COLITIS ULCERATIVE 780 0.0174
702 CLOSTRIDIUM DIFFICILE COLITIS 185 0.0174
703 LACERATION 164 0.0174
704 HOT FLUSH 1314 0.0174
705 THIRST 311 0.0174
706 PRODUCT USE IN UNAPPROVED INDICATION 4293 0.0173
707 EMPHYSEMA 174 0.0172
708 HAEMOPTYSIS 481 0.0172
709 ORAL PAIN 386 0.0172
710 ANAEMIA 3287 0.0172
711 ALOPECIA 3379 0.0172
712 ILLNESS 1770 0.0172
713 UPPER GASTROINTESTINAL HAEMORRHAGE 289 0.0172
714 RED BLOOD CELL COUNT DECREASED 489 0.0171
715 METASTASES TO BONE 280 0.0170
716 ELECTROLYTE IMBALANCE 198 0.0170
717 SUPRAVENTRICULAR TACHYCARDIA 163 0.0170
718 OESOPHAGITIS 186 0.0170
719 INFLUENZA LIKE ILLNESS 1400 0.0170
720 OROPHARYNGEAL PAIN 1572 0.0170
721 RESPIRATORY ARREST 468 0.0170
722 SINUS TACHYCARDIA 241 0.0170
723 COLITIS 643 0.0169
724 SARS-COV-2 TEST POSITIVE 224 0.0169
725 PAIN IN JAW 480 0.0169
726 EYE INFECTION 191 0.0169
727 ALANINE AMINOTRANSFERASE INCREASED 1038 0.0169
728 NEPHROLITHIASIS 774 0.0169
729 BLOOD CREATININE INCREASED 1101 0.0168
730 ARRHYTHMIA 797 0.0168
731 RENAL IMPAIRMENT 1412 0.0168
732 BRAIN FOG 263 0.0168
733 PLEURAL EFFUSION 1016 0.0167
734 RENAL FAILURE ACUTE 708 0.0167
735 LIVER FUNCTION TEST ABNORMAL 485 0.0167
736 POLLAKIURIA 695 0.0166
737 COUGH 4669 0.0166
738 SKIN DISCOLOURATION 765 0.0166
739 PULMONARY EMBOLISM 1580 0.0166
740 EYELID OEDEMA 193 0.0166
741 CENTRAL NERVOUS SYSTEM LESION 228 0.0166
742 LEUKOPENIA 827 0.0165
743 HYPERTENSIVE CRISIS 183 0.0164
744 MITRAL VALVE INCOMPETENCE 186 0.0164
745 CHROMATURIA 370 0.0164
746 MASS 229 0.0164
747 RESPIRATORY DISTRESS 452 0.0164
748 DRUG DISPENSING ERROR 250 0.0163
749 PRURITUS 6282 0.0163
750 CARDIAC FAILURE 1309 0.0163
751 RESPIRATORY FAILURE 1189 0.0163
752 DRUG PRESCRIBING ERROR 312 0.0162
753 HEART RATE INCREASED 1606 0.0162
754 PNEUMONITIS 441 0.0162
755 SKIN REACTION 228 0.0162
756 SUDDEN DEATH 171 0.0161
757 DRY THROAT 164 0.0161
758 METABOLIC ACIDOSIS 514 0.0161
759 CORONARY ARTERY OCCLUSION 220 0.0160
760 OFF LABEL USE 14045 0.0160
761 DIARRHOEA 10342 0.0160
762 COVID-19 PNEUMONIA 189 0.0160
763 BRONCHOSPASM 228 0.0160
764 TASTE DISORDER 324 0.0160
765 LUNG INFECTION 248 0.0159
766 BLINDNESS UNILATERAL 225 0.0159
767 HYPERGLYCAEMIA 581 0.0159
768 ELECTROCARDIOGRAM QT PROLONGED 573 0.0159
769 BACTERIAL INFECTION 297 0.0159
770 HYPOCALCAEMIA 301 0.0159
771 EYE SWELLING 590 0.0158
772 RETCHING 338 0.0158
773 CEREBROVASCULAR ACCIDENT 2676 0.0158
774 LABORATORY TEST ABNORMAL 465 0.0157
775 PANCREATITIS 831 0.0157
776 ORAL DISCOMFORT 218 0.0157
777 INTESTINAL OBSTRUCTION 590 0.0156
778 PLATELET COUNT INCREASED 204 0.0156
779 OSTEONECROSIS OF JAW 387 0.0156
780 DEEP VEIN THROMBOSIS 1012 0.0156
781 CHEST DISCOMFORT 1593 0.0155
782 RENAL INJURY 462 0.0155
783 POST PROCEDURAL COMPLICATION 298 0.0155
784 RASH MACULO-PAPULAR 345 0.0155
785 PANCREATITIS ACUTE 347 0.0154
786 DRUG EFFECT DECREASED 831 0.0154
787 CHOLELITHIASIS 505 0.0154
788 VASCULITIS 179 0.0154
789 VIRAL INFECTION 511 0.0153
790 FEBRILE NEUTROPENIA 1016 0.0153
791 THROMBOSIS 1232 0.0153
792 CHOLECYSTITIS 182 0.0153
793 ASPARTATE AMINOTRANSFERASE INCREASED 811 0.0153
794 BLOOD GLUCOSE FLUCTUATION 167 0.0152
795 RASH PRURITIC 825 0.0152
796 INFUSION SITE PAIN 196 0.0152
797 MALNUTRITION 170 0.0152
798 NEUROLEPTIC MALIGNANT SYNDROME 180 0.0152
799 SCAB 173 0.0152
800 HAEMOGLOBIN DECREASED 1555 0.0151
801 BLOOD CALCIUM DECREASED 170 0.0151
802 HAEMATOCRIT DECREASED 299 0.0151
803 NASAL CONGESTION 883 0.0150
804 CYANOSIS 236 0.0150
805 RASH ERYTHEMATOUS 717 0.0150
806 EYE HAEMORRHAGE 200 0.0150
807 GALLBLADDER DISORDER 267 0.0149
808 MATERNAL EXPOSURE DURING PREGNANCY 1328 0.0149
809 MULTIPLE FRACTURES 244 0.0148
810 DYSTONIA 287 0.0148
811 ABSCESS 236 0.0148
812 GLYCOSYLATED HAEMOGLOBIN INCREASED 373 0.0148
813 LYMPHOPENIA 209 0.0148
814 THERAPEUTIC RESPONSE DECREASED 888 0.0146
815 LACRIMATION INCREASED 442 0.0146
816 METASTASES TO LUNG 169 0.0146
817 CHOKING 285 0.0146
818 CORONARY ARTERY DISEASE 441 0.0145
819 PANCYTOPENIA 813 0.0145
820 NEOPLASM MALIGNANT 968 0.0145
821 TENDON RUPTURE 178 0.0144
822 MELAENA 317 0.0144
823 ANAPHYLACTIC REACTION 795 0.0144
824 PRURITUS GENERALISED 311 0.0144
825 FEMUR FRACTURE 445 0.0144
826 DERMATITIS 301 0.0144
827 SPLENOMEGALY 168 0.0143
828 ATRIAL FIBRILLATION 1390 0.0143
829 DEVICE RELATED INFECTION 219 0.0142
830 CARDIOMYOPATHY 210 0.0142
831 ECONOMIC PROBLEM 215 0.0142
832 ACUTE RESPIRATORY DISTRESS SYNDROME 250 0.0141
833 CARDIAC DISORDER 1321 0.0141
834 ADVERSE REACTION 187 0.0141
835 SEPTIC SHOCK 613 0.0141
836 BACTERAEMIA 167 0.0141
837 DERMATITIS ALLERGIC 176 0.0140
838 TOOTH LOSS 289 0.0139
839 HYPOMAGNESAEMIA 194 0.0139
840 LACTIC ACIDOSIS 449 0.0139
841 FLATULENCE 782 0.0138
842 LYMPHADENOPATHY 488 0.0138
843 PLATELET COUNT DECREASED 1466 0.0137
844 CONJUNCTIVITIS 255 0.0137
845 HEPATIC FUNCTION ABNORMAL 511 0.0137
846 THERAPY PARTIAL RESPONDER 213 0.0136
847 ERYTHEMA 2803 0.0136
848 PULMONARY HYPERTENSION 284 0.0136
849 CARDIAC FAILURE CONGESTIVE 1094 0.0136
850 CLOSTRIDIUM DIFFICILE INFECTION 295 0.0135
851 PSORIASIS 1753 0.0134
852 HYPERTHYROIDISM 194 0.0134
853 INTENTIONAL DOSE OMISSION 380 0.0133
854 THROAT TIGHTNESS 360 0.0133
855 FAECES DISCOLOURED 288 0.0133
856 BLOOD URINE PRESENT 252 0.0133
857 SURGERY 767 0.0131
858 PRODUCT ADMINISTRATION ERROR 262 0.0130
859 PLASMA CELL MYELOMA 505 0.0129
860 CARDIAC ARREST 1067 0.0129
861 ECZEMA 668 0.0128
862 COVID-19 2237 0.0127
863 PNEUMOTHORAX 198 0.0125
864 EXPIRED PRODUCT ADMINISTERED 415 0.0125
865 BLOOD COUNT ABNORMAL 189 0.0125
866 SHOCK 285 0.0124
867 MALIGNANT NEOPLASM PROGRESSION 1268 0.0124
868 ADVERSE DRUG REACTION 1106 0.0123
869 NEUTROPHIL COUNT DECREASED 501 0.0123
870 TACHYPNOEA 167 0.0123
871 WHITE BLOOD CELL COUNT DECREASED 1327 0.0122
872 UNEVALUABLE EVENT 924 0.0122
873 BLOOD GLUCOSE ABNORMAL 225 0.0122
874 ANHEDONIA 320 0.0122
875 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 313 0.0122
876 LEUKOCYTOSIS 220 0.0121
877 RASH MACULAR 424 0.0121
878 WRONG TECHNIQUE IN DRUG USAGE PROCESS 438 0.0120
879 RASH PAPULAR 270 0.0120
880 TREATMENT NONCOMPLIANCE 658 0.0120
881 SUBDURAL HAEMATOMA 172 0.0120
882 STEVENS-JOHNSON SYNDROME 265 0.0119
883 DIABETIC KETOACIDOSIS 285 0.0119
884 DISEASE PROGRESSION 1399 0.0118
885 ANGIOEDEMA 522 0.0118
886 FUNGAL INFECTION 393 0.0118
887 THROAT IRRITATION 529 0.0118
888 MUCOSAL INFLAMMATION 307 0.0117
889 ABDOMINAL PAIN LOWER 295 0.0117
890 DYSGEUSIA 863 0.0116
891 SKIN FISSURES 227 0.0116
892 PERICARDIAL EFFUSION 268 0.0116
893 EPISTAXIS 866 0.0116
894 COLON CANCER 172 0.0115
895 BLOOD GLUCOSE DECREASED 554 0.0115
896 PRODUCT PRESCRIBING ISSUE 249 0.0114
897 ISCHAEMIC STROKE 202 0.0113
898 ADVERSE EVENT 1042 0.0113
899 RASH GENERALISED 292 0.0113
900 NEUTROPENIA 1530 0.0112
901 MYOCARDIAL INFARCTION 1954 0.0112
902 MULTIPLE ORGAN DYSFUNCTION SYNDROME 317 0.0112
903 CEREBRAL INFARCTION 273 0.0112
904 JAUNDICE 300 0.0111
905 PRODUCT DOSE OMISSION 727 0.0111
906 BLOOD LACTATE DEHYDROGENASE INCREASED 175 0.0110
907 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 323 0.0110
908 DISEASE RECURRENCE 520 0.0109
909 EXTRAPYRAMIDAL DISORDER 270 0.0109
910 INSURANCE ISSUE 166 0.0108
911 NEUROTOXICITY 190 0.0108
912 THERAPEUTIC RESPONSE SHORTENED 357 0.0108
913 COAGULOPATHY 179 0.0107
914 INTERNATIONAL NORMALISED RATIO INCREASED 306 0.0107
915 EXPOSURE DURING PREGNANCY 661 0.0106
916 BLOOD BILIRUBIN INCREASED 286 0.0106
917 ACUTE MYOCARDIAL INFARCTION 312 0.0106
918 FLUSHING 1073 0.0105
919 BLOOD GLUCOSE INCREASED 1968 0.0104
920 SKIN EXFOLIATION 878 0.0104
921 BONE DENSITY DECREASED 326 0.0104
922 HEPATIC FAILURE 309 0.0102
923 BONE MARROW FAILURE 204 0.0100
924 VENTRICULAR TACHYCARDIA 165 0.0100
925 GASTROINTESTINAL HAEMORRHAGE 832 0.0099
926 PELVIC PAIN 180 0.0099
927 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1778 0.0099
928 METASTASES TO LIVER 173 0.0098
929 CEREBRAL HAEMORRHAGE 352 0.0098
930 UNDERDOSE 706 0.0097
931 LUNG NEOPLASM MALIGNANT 396 0.0096
932 CYTOKINE RELEASE SYNDROME 193 0.0096
933 OCULAR HYPERAEMIA 454 0.0096
934 HEPATOTOXICITY 210 0.0094
935 ANAPHYLACTIC SHOCK 242 0.0094
936 DRUG DOSE OMISSION 1546 0.0093
937 HAEMORRHAGE 975 0.0093
938 PRODUCT PHYSICAL ISSUE 187 0.0093
939 ERUCTATION 178 0.0092
940 PRODUCT DOSE OMISSION IN ERROR 260 0.0092
941 EYE IRRITATION 527 0.0091
942 PROTEINURIA 173 0.0091
943 AGEUSIA 225 0.0090
944 CARDIOVASCULAR DISORDER 225 0.0089
945 FULL BLOOD COUNT DECREASED 175 0.0087
946 OSTEONECROSIS 285 0.0087
947 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 600 0.0084
948 SKIN CANCER 181 0.0084
949 PAIN OF SKIN 223 0.0083
950 THERAPY CESSATION 420 0.0082
951 PRODUCT SUBSTITUTION ISSUE 467 0.0081
952 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 187 0.0080
953 PRODUCT AVAILABILITY ISSUE 182 0.0080
954 DRUG ADMINISTRATION ERROR 240 0.0078
955 PRODUCT ADHESION ISSUE 275 0.0077
956 NEOPLASM PROGRESSION 263 0.0076
957 PRODUCT DOSE OMISSION ISSUE 2204 0.0075
958 EMOTIONAL DISTRESS 890 0.0073
959 THERAPY INTERRUPTED 522 0.0073
960 TARDIVE DYSKINESIA 206 0.0073
961 HOSPITALISATION 1118 0.0073
962 ABORTION SPONTANEOUS 291 0.0073
963 DRUG RESISTANCE 182 0.0071
964 DRY SKIN 933 0.0070
965 INCORRECT DOSE ADMINISTERED 1512 0.0066
966 DEATH 5608 0.0065
967 VAGINAL HAEMORRHAGE 281 0.0065
968 EYE PRURITUS 213 0.0063
969 PRODUCT QUALITY ISSUE 836 0.0061
970 INJECTION SITE MASS 222 0.0060
971 SKIN BURNING SENSATION 427 0.0060
972 FOETAL EXPOSURE DURING PREGNANCY 475 0.0058
973 INJECTION SITE BRUISING 460 0.0058
974 ACNE 432 0.0057
975 INJECTION SITE PRURITUS 375 0.0056
976 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 174 0.0051
977 SKIN IRRITATION 228 0.0050
978 BREAST CANCER 456 0.0049
979 INJECTION SITE PAIN 1490 0.0049
980 INJECTION SITE ERYTHEMA 602 0.0048
981 DEPENDENCE 264 0.0048
982 INJECTION SITE REACTION 328 0.0048
983 DEVICE DISLOCATION 201 0.0046
984 DEVICE ISSUE 403 0.0045
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 889 0.0044
986 DEVICE MALFUNCTION 289 0.0041
987 INJECTION SITE HAEMORRHAGE 312 0.0039
988 NO ADVERSE EVENT 706 0.0039
989 INJECTION SITE SWELLING 291 0.0038
990 PROSTATE CANCER 231 0.0029
991 ACCIDENTAL EXPOSURE TO PRODUCT 248 0.0024
992 PRODUCT STORAGE ERROR 168 0.0019